Statement from FDA Commissioner Scott Gottlieb, M.D., on implementation of agency’s streamlined deve

U.S. Food & Drug Administration press release -------- At a time when people are more aware of and engaged in their health care than ever before, genetic risk testing can provide helpful information about an individual’s predisposition for certain diseases and conditions. These tests can prompt consumers to be more engaged in pursuing the benefits of healthy lifestyle choices and more aware of their health risks. Consumers are increasingly embracing genetic health risk (GHR) testing to better understand their individual risk for developing diseases. This engagement prompts some people to make more informed lifestyle choices. Direct-to-consumer (DTC) access to GHR tests is made possible by advances in technology. With a small saliva sample, consumers can retrieve their genetic risk result directly from the test provider’s website. As consumer interest in genetic risk information grows, opportunities are also expanding for the detection of additional genetic conditions and diseases that can help inform people of their medical risks. To learn more click on the picture below to read the release.